Nasdaq
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medtech and consumer devices. Its platform uses radiofrequency technology, which enables the creation of sensors that are small enough to fit into wearable devices and other small form factors. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano in August 2018.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $1.0M | $433,000.00 |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$11.1M | -$19.8M | -$30.5M | -$29.7M | -$24.2M | -$15.5M |
| Net income | -$13.0M | -$21.8M | -$30.3M | -$29.3M | -$23.7M | -$18.3M |
| Diluted EPS | — | -$0.92 | -$0.92 | -$9.51 | -$39.39 | -$21.79 |
| Operating cash flow | -$10.7M | -$16.2M | -$24.9M | -$26.2M | -$22.5M | -$11.3M |
| Free cash flow | — | -$16.7M | -$25.0M | -$26.2M | -$22.5M | — |
| Gross margin | — | — | — | — | — | — |
| Operating margin | — | — | — | — | -2391.1% | -3580.4% |
| Net margin | — | — | — | — | -2342.3% | -4222.9% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $23,000.00 | $50,000.00 | $88,000.00 | $206,000.00 | $103,000.00 | $80,000.00 | $44,000.00 | $510,000.00 |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$6.4M | -$7.4M | -$4.7M | -$5.2M | -$3.3M | -$2.6M | -$4.4M | -$4.8M |
| Net income | -$6.2M | -$7.2M | -$4.6M | -$5.2M | -$3.2M | -$4.0M | -$5.9M | -$5.0M |
| Diluted EPS | -$0.93 | -$10.56 | -$26.37 | -$5.35 | -$0.41 | -$4.73 | -$11.30 | -$3.13 |
| Operating cash flow | -$8.2M | -$5.7M | -$4.6M | -$4.3M | -$3.1M | -$1.6M | -$2.3M | -$4.3M |
| Free cash flow | -$8.2M | -$5.7M | -$4.6M | — | — | — | — | -$10.5M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | -27813.0% | -14758.0% | -5331.8% | -2542.7% | -3165.0% | -3238.8% | -10031.8% | -950.4% |
| Net margin | -26913.0% | -14402.0% | -5245.5% | -2513.6% | -3131.1% | -5036.3% | -13302.3% | -981.4% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-07 | Demsey Seth· Co-Chief Executive Officer | C | 31,270 | $0.00 | $0.00 | filing |
| 2026-07-07 | Crystal John Adler III· Co-Chief Executive Officer | C | 3,345,523 | $0.00 | $0.00 | filing |
| 2026-07-07 | Crystal John Adler III· Co-Chief Executive Officer | C | 708,154 | $0.00 | $0.00 | filing |
| 2026-07-07 | Demsey Seth· Co-Chief Executive Officer | C | 5,484,388 | $0.00 | $0.00 | filing |
| 2026-07-07 | FAIRBAIRN EMILY | C | 1,205,282 | $0.00 | $0.00 | filing |
| 2026-07-01 | FAIRBAIRN EMILY | Award | 135,800 | $0.00 | $0.00 | filing |
| 2026-07-01 | Moreland Christopher· CFO | Award | 523,211 | $0.00 | $0.00 | filing |
| 2026-07-01 | Fleury Patrick | Award | 100,000 | $0.00 | $0.00 | filing |
| 2026-07-01 | DONOFRIO NICHOLAS M | Award | 50,000 | $0.00 | $0.00 | filing |
| 2026-07-01 | Cullinan Brian | Award | 50,000 | $0.00 | $0.00 | filing |
| 2026-06-30 | Cullinan Brian | Option exercise | 48,209 | $0.92 | $44,352.28 | filing |
| 2026-06-25 | Caballero Ruben | Option exercise | 29,197 | $0.92 | $26,861.24 | filing |
| 2026-03-31 | Crystal John Adler III· Chief Executive Officer | C | 3,167 | $0.00 | $0.00 | filing |
| 2026-03-31 | Demsey Seth | C | 24,532 | $0.00 | $0.00 | filing |
| 2026-03-31 | Demsey Seth | C | 139 | $0.00 | $0.00 | filing |
| 2026-03-31 | Crystal John Adler III· Chief Executive Officer | C | 14,965 | $0.00 | $0.00 | filing |
| 2026-03-31 | FAIRBAIRN EMILY | C | 9,231 | $0.00 | $0.00 | filing |
| 2026-03-18 | Cogan Jeremy· CFO | Award | 37,000 | $0.00 | $0.00 | filing |
| 2026-03-16 | FAIRBAIRN EMILY | Option exercise | 55,250 | $1.25 | $69,062.50 | filing |
| 2026-03-13 | Wirk Shaheen | Option exercise | 10,000 | $1.25 | $12,500.00 | filing |
| 2026-01-27 | Mastrototaro John· Chief Executive Officer | Sale | 14,960 | $20.75 | $310,420.00 | filing |
| 2026-01-27 | Cogan Jeremy· CFO | Sale | 13,179 | $20.63 | $271,882.77 | filing |
| 2026-01-27 | Mastrototaro John· Chief Executive Officer | Sale | 5,746 | $21.78 | $125,147.88 | filing |
| 2026-01-27 | Cogan Jeremy· CFO | Sale | 5,548 | $21.76 | $120,724.48 | filing |
| 2026-01-27 | Mastrototaro John· Chief Executive Officer | Sale | 5,444 | $20.18 | $109,859.92 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.